Icon Pub Ltd Co (NASDAQ:ICLR)

CAPS Rating: 4 out of 5

The Company is a contract research organization, providing clinical research and development services on a global basis to the pharmaceutical, biotechnology and medical device industries.

Recs

1
Player Avatar dollarpimp (< 20) Submitted: 1/18/2008 7:38:32 PM : Outperform Start Price: $30.82 ICLR Score: +18.14

Discounted earnings valuation assuming 25% earnings growth over 10 years indicates this stock is selling at a substantial discount. Even assuming 20%, it's fairly priced. Just backed off a new high, buying on the dip. Healthcare sector will outperform.

Featured Broker Partners


Advertisement